Page last updated: 2024-08-23

daunorubicin and Pituitary Neoplasms

daunorubicin has been researched along with Pituitary Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bősze, S; Halmos, G; Kovács, M; Mező, G; Orbán, E; Sipos, É; Szabó, I	1

Other Studies

1 other study(ies) available for daunorubicin and Pituitary Neoplasms

Article	Year
Comparative in vitro biological evaluation of daunorubicin containing GnRH-I and GnRH-II conjugates developed for tumor targeting. Journal of peptide science : an official publication of the European Peptide Society, 2015, Volume: 21, Issue:5 Topics: Antineoplastic Agents, Hormonal; Apoptosis; Cell Line, Tumor; Cell Proliferation; Daunorubicin; Gonadotropin-Releasing Hormone; HT29 Cells; Humans; Male; MCF-7 Cells; Pituitary Neoplasms; Prostatic Neoplasms; Receptors, LHRH	2015

Article

Year

Comparative in vitro biological evaluation of daunorubicin containing GnRH-I and GnRH-II conjugates developed for tumor targeting.

Journal of peptide science : an official publication of the European Peptide Society, 2015, Volume: 21, Issue:5

Topics: Antineoplastic Agents, Hormonal; Apoptosis; Cell Line, Tumor; Cell Proliferation; Daunorubicin; Gonadotropin-Releasing Hormone; HT29 Cells; Humans; Male; MCF-7 Cells; Pituitary Neoplasms; Prostatic Neoplasms; Receptors, LHRH

2015